Literature DB >> 9505936

Abnormal development and differentiation of macrophages and dendritic cells in viable motheaten mutant mice deficient in haematopoietic cell phosphatase.

K Nakayama1, K Takahashi, L D Shultz, K Miyakawa, K Tomita.   

Abstract

In mice homozygous for the 'viable motheaten' (mev) mutation, numbers of macrophage progenitor cells, particularly monocytes, were markedly increased in the bone marrow and spleen. Increased mobilization of these precursor cells to peripheral tissues and their differentiation to macrophages were evidenced by striking increases in macrophage numbers. Immunohistochemical double staining of tissue sections and flow cytometry analyses of single cell suspensions from these mice demonstrated CD5 (Ly-1)-positive macrophages in the peritoneal cavity, spleen and other tissues. Ly-1-positive macrophage precursor cells were demonstrated in the peritoneal cavity of the mev mice and developed in the omental milky spots. The development of marginal metallophilic and marginal zone macrophages was poor in the splenic white pulp and related macrophage populations were absent in the other lymphoid tissues. The numbers of epidermal Langerhans cells in the skin and T cell-associated dendritic cells in the thymic medulla, lymph nodes, and the other peripheral lymphoid tissues were decreased. However, increased numbers of dendritic cells accumulated in the lungs, liver, and kidneys. These abnormalities in development and differentiation of macrophages and dendritic cells may be ascribed to the deficiency in haematopoietic cell SHP-1 tyrosine phosphatase or may be a secondary consequence of abnormal microenvironments, (either constitutive or in response to inflammatory stimuli) in the haematopoietic and lymphopoietic organs and tissues of these mice.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9505936      PMCID: PMC2694538          DOI: 10.1046/j.1365-2613.1997.250358.x

Source DB:  PubMed          Journal:  Int J Exp Pathol        ISSN: 0959-9673            Impact factor:   1.925


  10 in total

1.  Inhibition of protein tyrosine phosphatases enhances cerebral collateral growth in rats.

Authors:  Ivo Buschmann; Daniel Hackbusch; Nora Gatzke; André Dülsner; Manuela Trappiel; Markus Dagnell; Arne Ostman; Rob Hooft van Huijsduijnen; Kai Kappert
Journal:  J Mol Med (Berl)       Date:  2014-05-27       Impact factor: 4.599

2.  CD244 is expressed on dendritic cells and regulates their functions.

Authors:  Anna-Maria Georgoudaki; Sorosh Khodabandeh; Speranta Puiac; Catrine M Persson; Maria K Larsson; Max Lind; Oscar Hammarfjord; Tara H Nabatti; Robert P A Wallin; Ulf Yrlid; Mikael Rhen; Vinay Kumar; Benedict J Chambers
Journal:  Immunol Cell Biol       Date:  2015-02-03       Impact factor: 5.126

Review 3.  Shp1 function in myeloid cells.

Authors:  Clare L Abram; Clifford A Lowell
Journal:  J Leukoc Biol       Date:  2017-06-12       Impact factor: 4.962

4.  Deficiency of SHP-1 protein-tyrosine phosphatase activity results in heightened osteoclast function and decreased bone density.

Authors:  S Umeda; W G Beamer; K Takagi; M Naito; S Hayashi; H Yonemitsu; T Yi; L D Shultz
Journal:  Am J Pathol       Date:  1999-07       Impact factor: 4.307

5.  Tyrosine phosphatase SHP-1 is expressed higher in multisystem than in single-system Langerhans cell histiocytosis by immunohistochemistry.

Authors:  Ichiro Murakami; Takashi Oka; Satoshi Kuwamoto; Masako Kato; Kazuhiko Hayashi; Jean Gogusev; Toshihiko Imamura; Akira Morimoto; Shinsaku Imashuku; Tadashi Yoshino
Journal:  Virchows Arch       Date:  2011-05-22       Impact factor: 4.064

6.  T-cell protein tyrosine phosphatase (Tcptp) is a negative regulator of colony-stimulating factor 1 signaling and macrophage differentiation.

Authors:  Paul D Simoncic; Annie Bourdeau; Ailsa Lee-Loy; Larry R Rohrschneider; Michel L Tremblay; E Richard Stanley; C Jane McGlade
Journal:  Mol Cell Biol       Date:  2006-06       Impact factor: 4.272

Review 7.  The role and target potential of protein tyrosine phosphatases in cancer.

Authors:  Taolin Yi; Daniel Lindner
Journal:  Curr Oncol Rep       Date:  2008-03       Impact factor: 5.075

Review 8.  Protein tyrosine phosphatase SHP-1: resurgence as new drug target for human autoimmune disorders.

Authors:  Yadhu Sharma; Samina Bashir; Puja Bhardwaj; Altaf Ahmad; Farah Khan
Journal:  Immunol Res       Date:  2016-08       Impact factor: 2.829

9.  Could a B-1 cell derived phagocyte "be one" of the peritoneal macrophages during LPS-driven inflammation?

Authors:  Ana Flavia Popi; Lika Osugui; Katia Regina Perez; Ieda Maria Longo-Maugéri; Mario Mariano
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

10.  Phosphatase inhibitor, sodium stibogluconate, in combination with interferon (IFN) alpha 2b: phase I trials to identify pharmacodynamic and clinical effects.

Authors:  Taolin Yi; Paul Elson; Masato Mitsuhashi; Barbara Jacobs; Emese Hollovary; Thomas G Budd; Timothy Spiro; Pierre Triozzi; Ernest C Borden
Journal:  Oncotarget       Date:  2011-12
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.